$1017.78
29.162.95%
In chiusura: -
$1021.75
3.970.39%
After hour: 7:59 PM EDT
Comments
Loading...
Guidance e previsioni
Eli Lilly fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
10/30/2025 | LLY | Eli Lilly | FY | 2025 | $23.00 | $23.70 | $22.68 | $63.00B | $63.50B | $62.26B | |
08/07/2025 | LLY | Eli Lilly | FY | 2025 | $21.75 | $23.00 | $22.01 | $60.00B | $62.00B | $60.23B | |
05/01/2025 | LLY | Eli Lilly | FY | 2025 | $20.78 | $22.28 | $22.40 | $58.00B | $61.00B | $59.57B | |
02/06/2025 | LLY | Eli Lilly | FY | 2025 | $22.50 | $24.00 | $22.69 | $58.00B | $61.00B | $58.91B | |
01/14/2025 | LLY | Eli Lilly | FY | 2025 | — | — | — | $58.00B | $61.00B | $58.48B | |
01/14/2025 | LLY | Eli Lilly | FY | 2024 | — | — | — | $45.00B | $45.00B | $45.55B | |
01/14/2025 | LLY | Eli Lilly | Q4 | 2024 | — | — | — | $13.50B | $13.50B | $13.95B | |
10/30/2024 | LLY | Eli Lilly | FY | 2024 | $13.02 | $13.52 | $13.47 | $45.40B | $46.00B | $46.24B | |
08/08/2024 | LLY | Eli Lilly | FY | 2024 | $16.10 | $16.60 | $13.76 | $45.40B | $46.60B | $43.01B | |
04/30/2024 | LLY | Eli Lilly and Co | FY | 2024 | $13.50 | $14.00 | $12.50 | $42.40B | $43.60B | $41.44B | |
02/06/2024 | LLY | Eli Lilly | FY | 2024 | $12.20 | $12.70 | $12.43 | $40.40B | $41.60B | $39.38B | |
11/02/2023 | LLY | Eli Lilly | FY | 2023 | $6.50 | $6.70 | $6.72 | $33.40B | $33.90B | $33.52B | |
08/08/2023 | LLY | Eli Lilly | FY | 2023 | $9.70 | $9.90 | $8.71 | $33.40B | $33.90B | $31.44B | |
04/27/2023 | LLY | Eli Lilly | FY | 2023 | $8.65 | $8.85 | $8.45 | $31.20B | $31.70B | $30.64B | |
02/02/2023 | LLY | Eli Lilly | FY | 2023 | $8.35 | $8.55 | $8.28 | $30.30B | $30.80B | $30.55B | |
01/19/2023 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $8.27 | $30.30B | $30.80B | $30.48B | |
12/13/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.78 | $28.50B | $29.00B | $28.62B | |
12/13/2022 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $9.15 | $30.30B | $30.80B | $30.12B | |
11/01/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.99 | $28.50B | $29.00B | $28.85B | |
08/04/2022 | LLY | Eli Lilly | FY | 2022 | $7.90 | $8.05 | $8.08 | $28.80B | $29.30B | $28.27B | |
04/28/2022 | LLY | Eli Lilly | FY | 2022 | $8.15 | $8.30 | $8.19 | $28.80B | $29.30B | $26.80B | |
02/03/2022 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.54 | $27.80B | $28.30B | $24.88B | |
12/15/2021 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.30 | $27.80B | $28.30B | $24.73B | |
12/15/2021 | LLY | Eli Lilly | FY | 2021 | $8.15 | $8.20 | $7.13 | $28.00B | $28.30B | $24.57B |
FAQ
Qual è la guidance più recente per Eli Lilly (LLY)?
Le ultime previsioni per Eli Lilly (LLY) sono state riportate il ottobre 30, 2025 per l'intero anno 2025. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $23.00 a $23.70, rispetto all'EPS stimato di $22.68. Inoltre, Eli Lilly ha previsto ricavi tra $63.00B e $63.50B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.